Physician profile
Mandy Yi
NPI 1932659984
$1,285.94
in general payments reported to CMS, 2019-2025
14 companies · $400 in 2025
The $400 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $225 · 2022: $84.84 · 2023: $267 · 2024: $309 · 2025: $400.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $976.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $975.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $315.63 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $214.51 | 2021-2024 | Andexxa |
| Pfizer INC. | $165.71 | 2022-2025 | |
| Gilead Sciences, INC. | $124.99 | 2025 | Veklury |
| Abbvie INC. | $114.47 | 2021-2025 | |
| Bioxcel Therapeutics, INC. | $90.26 | 2023 | Igalmi |
| Lilly USA, LLC | $75.44 | 2023-2025 | Mounjaro, Zepbound |
| Exact Sciences Corporation | $49.01 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Dexcom, INC. | $34.91 | 2025 | Dexcom G6 Transmitter |
| Astellas Pharma US INC | $21.85 | 2025 | Veozah |
| Csl Behring | $21.02 | 2021 | |
| Echosens North America, INC. | $20.46 | 2024 | Fibroscan |
| Bayer Healthcare Pharmaceuticals INC. | $18.86 | 2023 | |
| Abbott Laboratories | $18.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mandy Yi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.